Jean-Michel Linget

Title: Jean-Michel Linget: Innovator in Cannabinoid Research

Introduction

Jean-Michel Linget is a notable inventor based in Hoersholm, Denmark. He has made significant contributions to the field of cannabinoid research, particularly in the development of compounds that modulate cannabinoid receptors. His work is particularly relevant in the context of treating obesity and related conditions.

Latest Patents

Jean-Michel Linget holds 3 patents that focus on cannabinoid receptor modulators. His latest patents include innovative compounds that serve as modulators of the cannabinoid receptor CB1. These compounds are designed to suppress normal signaling activity of CB1 receptors, making them useful in the treatment of obesity and overweight. The detailed chemical formulas and structures of these compounds highlight their potential therapeutic applications.

Career Highlights

Linget's career is marked by his dedication to advancing cannabinoid research. His work has garnered attention for its potential to address significant health issues related to obesity. He is associated with 7tm Pharma A/S, a company that focuses on developing innovative therapies.

Collaborations

Throughout his career, Jean-Michel Linget has collaborated with esteemed colleagues, including Jean-Marie Receveur and Thomas Hoegberg. These collaborations have contributed to the advancement of research in cannabinoid modulation.

Conclusion

Jean-Michel Linget's contributions to cannabinoid research and his innovative patents position him as a key figure in the field. His work continues to pave the way for new treatments for obesity and related conditions.